Applications of SV-AUC During the Development of Lipid Nanoparticles and Viral Vectors

This 56-minute webinar explores the applications of sedimentation velocity analytical ultracentrifugation (SV-AUC) in developing lipid nanoparticles and viral vectors. Presented by Dr. Klaus Richter from Coriolis Pharma Research, learn how SV-AUC provides accurate size, oligomerization state, and impurity content analysis without the interference of matrix interactions—a critical advantage over methods like high performance size exclusion chromatography. Discover through detailed case studies how SV-AUC has become essential for developing lipid nanoparticles (LNPs), adeno-associated virus (AAV) therapeutics, and lentiviral vectors. Understand why this analytical method is increasingly adopted as a standard approach for both development and GMP-compliant batch release of novel vaccines and viral vector-based advanced therapy medicinal products (ATMPs).